Prostate Cancer Clinical Trial

Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping

Summary

The purpose of this study is to determine if the planning of radiation treatment of prostate cancer patient can be made more precise by comparing currently planning techniques to an imaging technique called SPECT.

View Full Description

Full Description

Single photon emission computed tomography (SPECT) uses radioactive tracers and a scanner to record data that a computer constructs into two- or three-dimensional images. A small amount of a radioactive drug is injected into the body and a scanner is used to make detailed images of areas inside the body where the radioactive material is taken up by the cells. Using a gamma camera (a special kind of scanner), we can create a better picture of the lymph node region. We will compare these pictures to images from your CT scan, to help plan your therapy.

The research in this study involves seeing if it is feasible to use SPECT scanning procedures for the purpose of planning your radiation treatment. We hope that doing so will allow us to more accurately and precisely plan radiation treatment to potential sites of cancer, and avoid delivering too much radiation to normal

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with biopsy proven adenocarcinoma of the prostate
Patients with at least one of the following high risk clinical features at the time of presentation:
Extra-prostatic extension (on palpation or radiographic imaging)
PSA ≥ 20
Gleason Score ≥ 8
Patients scheduled to receive prostatic and pelvic IMRT with ACCULOC® target localization
Age > 18 years
ECOG Performance Status ≤ 2
Willing and able to sign informed consent document.-

Exclusion Criteria:

History of radical prostatectomy
History of prior pelvic radiation-

Study is for people with:

Prostate Cancer

Estimated Enrollment:

15

Study ID:

NCT00608920

Recruitment Status:

Completed

Sponsor:

Washington University School of Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Washington University School of Medicine
St. Louis Missouri, 63110, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

15

Study ID:

NCT00608920

Recruitment Status:

Completed

Sponsor:


Washington University School of Medicine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider